Trade Summary

1 week ago, Clark David Michael, serving as Chief People Officer at Amicus Therapeutics, Inc. (FOLD), sold 25,642 shares at $14.17 per share, for a total transaction value of $363,380.00. Following this transaction, Clark David Michael now holds 245,690 shares of FOLD.

This sale represents a 9.00% decrease in Clark David Michael's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 4 days after the trade was made.

Amicus Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.